Cardiopulmonary Bypass Equipment – Medical Devices Pipeline Assessment, 2020

Cardiopulmonary bypass equipment temporarily takes over the function of heart and lungs during an open heart surgery. GlobalData's Medical Devices sector report, “Cardiopulmonary Bypass Equipment-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Cardiopulmonary Bypass Equipment pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Cardiopulmonary Bypass Equipment Pipeline Assessment report provides key information and data related to:

Extensive coverage of the Cardiopulmonary Bypass Equipment under development

Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths and estimated approval dates

Reviews of major players involved in the pipeline product development.

Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and, the number of trials of the major Cardiopulmonary Bypass Equipment pipeline products.

Review of Recent Developments in the segment / industry

The Cardiopulmonary Bypass Equipment Pipeline Assessment report enables you to:

Access significant competitor information, analysis, and insights to improve your R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Cardiopulmonary bypass equipment under development

Formulate market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

The major companies covered in the “Cardiopulmonary Bypass Equipment- Medical Devices Pipeline Assessment, 2020” report:

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

The GlobalData Differentiation

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025

• 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports

• 64,000+ medical equipment company profiles

• 5,600+ company profiles of medical equipment manufacturers in China and India

• 2,200+ company profiles of medical equipment manufacturers in Japan

• 1,200+ companies’ revenue splits and market shares

• 1,600+ quarterly and annual medical equipment company financials

• 850+ medical equipment company SWOTs

• 28,000+ pipeline product profiles

• 56,400+ marketed product profiles

• 47,000+ clinical trials

• 41,500+ trial investigators

• 7,000+ reports on companies with products in development

• 44,000+ deals in the medical equipment industry

• 1,100+ surgical and diagnostic procedures by therapy area

• 50+ key healthcare indicators by country

• 431,000+ Themes Content Items

• 600+ Influencers

• 1,900+ Analysts & Researchers

• 0.5m+ Community Members

• 141,000+ Macroeconomic Indicators

• 1,013,000+ City Indicators

For more information or to receive a free demonstration of the service, please visit:

https://medical.globaldata.com/home.aspx

Custom Requirements

Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

– Extensive coverage of the Cardiopulmonary Bypass Equipment under development

– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

– The report reviews the major players involved in the development of Cardiopulmonary Bypass Equipment and list all their pipeline projects

– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

– The report provides key clinical trial data of ongoing trials specific to pipeline products

– Recent developments in the segment / industry

Reasons to buy

The report enables you to:

– Formulate significant competitor information, analysis, and insights to improve R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

– Identify and understand important and diverse types of Cardiopulmonary Bypass Equipment under development

– Develop market-entry and market expansion strategies

– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

– In-depth analysis of the product’s current stage of development, territory and estimated launch date

Companies mentioned

AngioDynamics Inc

Circulatory Technology Inc.

CVD Equipment Corp

Elsius Biomedical Inc

Ension, Inc.

Getinge AB

Haemair Ltd

Hemovent GmbH

LivaNova PLC

Mayo Clinic

MC3 Inc

McGowan Institute for Regenerative Medicine

MedArray Inc.

Monash University

Nikkiso Co Ltd

Nipro Corp

Shandong University

Sree Chitra Tirunal Institute for Medical Sciences & Technology

Terumo Cardiovascular Systems Corp

The Charles Stark Draper Laboratory Inc

Thoratec LLC

University of California San Francisco

University of Michigan

University of Pittsburgh

University of Strathclyde

VentriFlo Inc

Xenios AG

Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 6

2 Introduction 7

2.1 Cardiopulmonary Bypass Equipment Overview 7

3 Products under Development 8

3.1 Cardiopulmonary Bypass Equipment – Pipeline Products by Stage of Development 8

3.2 Cardiopulmonary Bypass Equipment – Pipeline Products by Territory 9

3.3 Cardiopulmonary Bypass Equipment – Pipeline Products by Regulatory Path 10

3.4 Cardiopulmonary Bypass Equipment – Pipeline Products by Estimated Approval Date 11

3.5 Cardiopulmonary Bypass Equipment – Ongoing Clinical Trials 12

4 Cardiopulmonary Bypass Equipment – Pipeline Products under Development by Companies 13

4.1 Cardiopulmonary Bypass Equipment Companies – Pipeline Products by Stage of Development 13

4.2 Cardiopulmonary Bypass Equipment – Pipeline Products by Stage of Development 15

5 Cardiopulmonary Bypass Equipment Companies and Product Overview 16

5.1 AngioDynamics Inc Company Overview 16

5.1.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 16

5.2 Circulatory Technology Inc. Company Overview 18

5.2.1 Circulatory Technology Inc. Pipeline Products & Ongoing Clinical Trials Overview 18

5.3 CVD Equipment Corp Company Overview 19

5.3.1 CVD Equipment Corp Pipeline Products & Ongoing Clinical Trials Overview 19

5.4 Elsius Biomedical Inc Company Overview 20

5.4.1 Elsius Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 20

5.5 Ension, Inc. Company Overview 21

5.5.1 Ension, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21

5.6 Getinge AB Company Overview 22

5.6.1 Getinge AB Pipeline Products & Ongoing Clinical Trials Overview 22

5.7 Haemair Ltd Company Overview 23

5.7.1 Haemair Ltd Pipeline Products & Ongoing Clinical Trials Overview 23

5.8 Hemovent GmbH Company Overview 24

5.8.1 Hemovent GmbH Pipeline Products & Ongoing Clinical Trials Overview 24

5.9 LivaNova PLC Company Overview 27

5.9.1 LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview 27

5.10 Mayo Clinic Company Overview 30

5.10.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 30

5.11 MC3 Inc Company Overview 31

5.11.1 MC3 Inc Pipeline Products & Ongoing Clinical Trials Overview 31

5.12 McGowan Institute for Regenerative Medicine Company Overview 32

5.12.1 McGowan Institute for Regenerative Medicine Pipeline Products & Ongoing Clinical Trials Overview 32

5.13 MedArray Inc. Company Overview 33

5.13.1 MedArray Inc. Pipeline Products & Ongoing Clinical Trials Overview 33

5.14 Monash University Company Overview 36

5.14.1 Monash University Pipeline Products & Ongoing Clinical Trials Overview 36

5.15 Nikkiso Co Ltd Company Overview 37

5.15.1 Nikkiso Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 37

5.16 Nipro Corp Company Overview 38

5.16.1 Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview 38

5.17 Shandong University Company Overview 40

5.17.1 Shandong University Pipeline Products & Ongoing Clinical Trials Overview 40

5.18 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 41

5.18.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 41

5.19 Terumo Cardiovascular Systems Corp Company Overview 42

5.19.1 Terumo Cardiovascular Systems Corp Pipeline Products & Ongoing Clinical Trials Overview 42

5.20 The Charles Stark Draper Laboratory Inc Company Overview 43

5.20.1 The Charles Stark Draper Laboratory Inc Pipeline Products & Ongoing Clinical Trials Overview 43

5.21 Thoratec LLC Company Overview 44

5.21.1 Thoratec LLC Pipeline Products & Ongoing Clinical Trials Overview 44

5.22 University of California San Francisco Company Overview 45

5.22.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 45

5.23 University of Michigan Company Overview 46

5.23.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 46

5.24 University of Pittsburgh Company Overview 47

5.24.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 47

5.25 University of Strathclyde Company Overview 48

5.25.1 University of Strathclyde Pipeline Products & Ongoing Clinical Trials Overview 48

5.26 VentriFlo Inc Company Overview 49

5.26.1 VentriFlo Inc Pipeline Products & Ongoing Clinical Trials Overview 49

5.27 Xenios AG Company Overview 50

5.27.1 Xenios AG Pipeline Products & Ongoing Clinical Trials Overview 50

6 Cardiopulmonary Bypass Equipment- Recent Developments 52

6.1 Aug 13, 2020: Medline joins NPPGov as an approved vendor offering top-notch medical supplies 52

6.2 Feb 26, 2020: LivaNova reports fourth quarter and full-year 2019 results 52

6.3 Feb 26, 2020: Mayo Clinic reports 'remarkable growth' in 2019 54

6.4 Feb 25, 2020: LivaNova receives FDA clearance for 3T Heater-Cooler Device Modification 55

6.5 Feb 24, 2020: 2020 Catalyst award winner Medtronic hires Chief Inclusion and Diversity Officer 55

6.6 Feb 24, 2020: 2020 Catalyst Award Winner Medtronic hires Chief Inclusion and Diversity Officer 56

6.7 Feb 18, 2020: Medtronic reports third quarter financial results 2020 56

6.8 Feb 06, 2020: AngioDynamics appoints Stephen Trowbridge Executive Vice President and Chief Financial Officer 59

6.9 Jan 07, 2020: AngioDynamics reports fiscal 2020 second quarter financial results 59

6.10 Dec 23, 2019: Mayo Clinic names chief digital officer to lead transformative digital strategy, create Center for Digital Health 61

6.11 Dec 19, 2019: The Children's Heart Foundation funds new research into congenital heart defects 61

6.12 Dec 04, 2019: Getinge is announcing a voluntary recall of the ROTAFLOW drive unit 62

6.13 Dec 04, 2019: Lumeon and Medtronic partner to deliver new models of care in Europe 62

6.14 Dec 03, 2019: Dr. John Halamka named president of Mayo Clinic Platform 63

6.15 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 64

6.16 Nov 18, 2019: CE Approval for Quantum Centrifugal Pump Drive systems 66

6.17 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 66

6.18 Oct 30, 2019: LivaNova reports third quarter 2019 results 67

6.19 Oct 23, 2019: Edwards Lifesciences reports third quarter results 68

6.20 Oct 22, 2019: AngioDynamics announces departure of CFO and appointment of interim CFO 71

6.21 Oct 21, 2019: Sean Salmon named executive vice president and group president of Medtronic Diabetes 72

6.22 Oct 10, 2019: CINDE announces Edwards Lifesciences invests $100 million to expand its operations in Costa Rica 73

6.23 Oct 03, 2019: AngioDynamics reports fiscal 2020 first quarter financial results 74

6.24 Sep 30, 2019: Getinge continues to focus on advancing patient care in cardiovascular and cardiothoracic procedures 75

6.25 Sep 25, 2019: Ron Smith Elected Board Chairman for AdventHealth 76

6.26 Sep 24, 2019: Getinge presents intensive care portfolio at European Society of Intensive Care Medicine Congress 2019 77

6.27 Sep 20, 2019: Terumo to increase production capacity for alliance business 77

6.28 Sep 17, 2019: AdventHealth, Moffitt Cancer Center join forces to improve cancer care for Floridians 78

7 Appendix 79

7.1 Methodology 79

7.2 About GlobalData 83

7.3 Contact Us 83

7.4 Disclaimer 83

List of Tables

Table 1: Cardiopulmonary Bypass Equipment – Pipeline Products by Stage of Development 8

Table 2: Cardiopulmonary Bypass Equipment – Pipeline Products by Territory 9

Table 3: Cardiopulmonary Bypass Equipment – Pipeline Products by Regulatory Path 10

Table 4: Cardiopulmonary Bypass Equipment – Pipeline Products by Estimated Approval Date 11

Table 5: Cardiopulmonary Bypass Equipment – Ongoing Clinical Trials 12

Table 6: Cardiopulmonary Bypass Equipment Companies – Pipeline Products by Stage of Development 13

Table 7: Cardiopulmonary Bypass Equipment – Pipeline Products by Stage of Development 15

Table 8: AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 16

Table 9: AngioVac – Generation 3 – Product Status 16

Table 10: AngioVac – Generation 3 – Product Description 17

Table 11: AngioVac – Generation 4 – Product Status 17

Table 12: AngioVac – Generation 4 – Product Description 17

Table 13: Circulatory Technology Inc. Pipeline Products & Ongoing Clinical Trials Overview 18

Table 14: Heart Lung Machine – Product Status 18

Table 15: Heart Lung Machine – Product Description 18

Table 16: CVD Equipment Corp Pipeline Products & Ongoing Clinical Trials Overview 19

Table 17: Extracorporeal Membrane Oxygenation Device – Product Status 19

Table 18: Extracorporeal Membrane Oxygenation Device – Product Description 19

Table 19: Elsius Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 20

Table 20: ECMO Portable Device – Product Status 20

Table 21: ECMO Portable Device – Product Description 20

Table 22: Ension, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21

Table 23: pCAS – Product Status 21

Table 24: pCAS – Product Description 21

Table 25: Getinge AB Pipeline Products & Ongoing Clinical Trials Overview 22

Table 26: Heart-Lung Machine HL 40 – Product Status 22

Table 27: Heart-Lung Machine HL 40 – Product Description 22

Table 28: Haemair Ltd Pipeline Products & Ongoing Clinical Trials Overview 23

Table 29: Extracorporeal Membrane Oxygenation (ECMO) Device – Product Status 23

Table 30: Extracorporeal Membrane Oxygenation (ECMO) Device – Product Description 23

Table 31: Hemovent GmbH Pipeline Products & Ongoing Clinical Trials Overview 24

Table 32: Mobybox – Product Status 24

Table 33: Mobybox – Product Description 24

Table 34: Hemovent GmbH – Ongoing Clinical Trials Overview 25

Table 35: Mobybox – A Post Market Surveillance Study of the Hemovent Extracorporeal Cardiopulmonary Support System for Cardiac and Respiratory Support: The MOBYBOX Trial 26

Table 36: LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview 27

Table 37: LBATS – Product Status 27

Table 38: LBATS – Product Description 27

Table 39: New Oxy Apex HP Oxygenator – Product Status 28

Table 40: New Oxy Apex HP Oxygenator – Product Description 28

Table 41: Next Generation ECMO System – Product Status 28

Table 42: Next Generation ECMO System – Product Description 29

Table 43: NINO – Product Status 29

Table 44: NINO – Product Description 29

Table 45: Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 30

Table 46: Heart-Lung Machine Reservoir Sensor – Product Status 30

Table 47: Heart-Lung Machine Reservoir Sensor – Product Description 30

Table 48: MC3 Inc Pipeline Products & Ongoing Clinical Trials Overview 31

Table 49: PedOxy – Product Status 31

Table 50: PedOxy – Product Description 31

Table 51: McGowan Institute for Regenerative Medicine Pipeline Products & Ongoing Clinical Trials Overview 32

Table 52: Biohybrid Artificial Lung – Product Status 32

Table 53: Biohybrid Artificial Lung – Product Description 32

Table 54: MedArray Inc. Pipeline Products & Ongoing Clinical Trials Overview 33

Table 55: ECMO Oxygenator – Adult – Product Status 33

Table 56: ECMO Oxygenator – Adult – Product Description 33

Table 57: ECMO Oxygenator – Neonatal – Product Status 34

Table 58: ECMO Oxygenator – Neonatal – Product Description 34

Table 59: ECMO Oxygenator – Pediatric – Product Status 34

Table 60: ECMO Oxygenator – Pediatric – Product Description 35

Table 61: Monash University Pipeline Products & Ongoing Clinical Trials Overview 36

Table 62: Cardio By-Pass Machine – Product Status 36

Table 63: Cardio By-Pass Machine – Product Description 36

Table 64: Nikkiso Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 37

Table 65: Cardiopulmonary Bypass Pump – Product Status 37

Table 66: Cardiopulmonary Bypass Pump – Product Description 37

Table 67: Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview 38

Table 68: Extracorporeal Membrane Oxygenator – Product Status 38

Table 69: Extracorporeal Membrane Oxygenator – Product Description 38

Table 70: Venous And Arterial Cannula – Product Status 39

Table 71: Venous And Arterial Cannula – Product Description 39

Table 72: Shandong University Pipeline Products & Ongoing Clinical Trials Overview 40

Table 73: ECMO Device – Product Status 40

Table 74: ECMO Device – Product Description 40

Table 75: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 41

Table 76: Paediatric And Neonatal Arterial Filter – Product Status 41

Table 77: Paediatric And Neonatal Arterial Filter – Product Description 41

Table 78: Terumo Cardiovascular Systems Corp Pipeline Products & Ongoing Clinical Trials Overview 42

Table 79: CAPIOX NX19 Oxygenator – Product Status 42

Table 80: CAPIOX NX19 Oxygenator – Product Description 42

Table 81: The Charles Stark Draper Laboratory Inc Pipeline Products & Ongoing Clinical Trials Overview 43

Table 82: Lung Assist – Product Status 43

Table 83: Lung Assist – Product Description 43

Table 84: Thoratec LLC Pipeline Products & Ongoing Clinical Trials Overview 44

Table 85: PediPL System – Product Status 44

Table 86: PediPL System – Product Description 44

Table 87: University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 45

Table 88: ECMO Oxygenator – Product Status 45

Table 89: ECMO Oxygenator – Product Description 45

Table 90: University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 46

Table 91: M-Lung – Product Status 46

Table 92: M-Lung – Product Description 46

Table 93: University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 47

Table 94: Portable Emergency Cardiopulmonary Bypass Device – Product Status 47

Table 95: Portable Emergency Cardiopulmonary Bypass Device – Product Description 47

Table 96: University of Strathclyde Pipeline Products & Ongoing Clinical Trials Overview 48

Table 97: Neonatal Life Support System – Product Status 48

Table 98: Neonatal Life Support System – Product Description 48

Table 99: VentriFlo Inc Pipeline Products & Ongoing Clinical Trials Overview 49

Table 100: VentriFlo True Pulse Pump – Product Status 49

Table 101: VentriFlo True Pulse Pump – Product Description 49

Table 102: Xenios AG Pipeline Products & Ongoing Clinical Trials Overview 50

Table 103: i-lung – Product Status 50

Table 104: i-lung – Product Description 50

Table 105: Xtralung – Product Status 51

Table 106: Xtralung – Product Description 51

Table 107: Glossary 82

List of Figures

Figure 1: Cardiopulmonary Bypass Equipment – Pipeline Products by Stage of Development 8

Figure 2: Cardiopulmonary Bypass Equipment – Pipeline Products by Territory 9

Figure 3: Cardiopulmonary Bypass Equipment – Pipeline Products by Regulatory Path 10

Figure 4: Cardiopulmonary Bypass Equipment – Pipeline Products by Estimated Approval Date 11

Figure 5: Cardiopulmonary Bypass Equipment – Ongoing Clinical Trials 12

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2745

Join our mailing list

Saved reports